COMPOSITIONA AND METHODS USEFUL FOR HCV INFECTION

Details for Australian Patent Application No. 2002306946 (hide)

Owner VERTEX PHARMACEUTICALS INCORPORATED

Inventors BYRN, Randal; REID, Lola, M.; KWONG, Ann

Pub. Number AU-A-2002306946

PCT Number PCT/US02/09685

PCT Pub. Number WO2002/077206

Priority 60/279,174 27.03.01 US

Filing date 27 March 2002

Wipo publication date 8 October 2002

International Classifications

C12N 005/00 Undifferentiated human, animal or plant cells, e.g. cell lines

C12Q 001/70 Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

C12N 007/00 Viruses, e.g. bacteriophages

C12N 015/85 Mutation or genetic engineering - for animal cells

C12N 015/86 Mutation or genetic engineering - Viral vectors

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/279,174 27.03.01 US

27 March 2003 Application Open to Public Inspection

  Published as AU-A-2002306946

22 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002306947-A METHOD FOR GENOTYPING INDIVIDUALS FOR MULTIPLE SNPS

2002306945-METHODS AND SYSTEMS FOR IMPLEMENTING A PROFITABILITY MODEL